A novel acute HIV infection staging system based on 4th generation immunoassay

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Ananworanich, Jintanat ^a,b,c,d   Fletcher, James L K ^a,b   Pinyakorn, Suteeraporn ^a,b,c   van Griensven, Frits ^b,c   Vandergeeten, Claire ^e   Schuetz, Alexandra ^f   Pankam, Tippawan ^b   Trichavaroj, Rapee ^f   Akapirat, Siriwat ^f   Chomchey, Nitiya ^a,b   Phanuphak, Praphan ^a,b,c,d   Chomont, Nicolas ^e   Michael, Nelson L ^g   Kim, Jerome H ^a,g   de Souza, Mark ^a,b  

^a SEARCH   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e Vaccine and Gene Therapy Institute of Florida   (United States)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^g US Military HIV Research Program   (United States)

Author keywords

2nd generation EIA; 4th generation EIA; 4thG stage; Acute HIV infection; Enzyme immunoassay; Fiebig stage; Functional cure; Nucleic acid testing; Primary HIV infection; Reservoir

Indexed keywords

VIRUS DNA; VIRUS RNA;

ACUTE HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ADULT; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE CLASSIFICATION; ENZYME IMMUNOASSAY; EXPOSURE; FEMALE; FOURTH GENERATION IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NUCLEIC ACID ANALYSIS; SCREENING; STAGING; WESTERN BLOTTING;

ADULT; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOASSAY; KILLER CELLS, NATURAL; MALE; MASS SCREENING; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VIRAL LOAD;

EID: 84878214420     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-56     Document Type: Article

References (24)

1. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005, 191:1403-1409. 10.1086/429411, 15809897.
2. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med 2011, 364:1943-1954. 10.1056/NEJMra1011874, 21591946.
3. Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ, Ahuja SK. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 2013, 368:218-230. 10.1056/NEJMoa1110187, 23323898.
4. Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012, 7:e33948. 10.1371/journal.pone.0033948, 3316511, 22479485.
5. O'Brien M, Markowitz M. Should we treat acute HIV infection?. Curr HIV/AIDS Rep 2012, 9:101-110. 10.1007/s11904-012-0113-0, 22415472.
6. Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun TW, Churchill M, Di Mascio M, Katlama C. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012, 12:607-614. 10.1038/nri3262, 3595991, 22814509.
7. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, Martinson FE, Cohen MS. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011, 378:256-268. 10.1016/S0140-6736(11)60842-8, 3274419, 21684591.
8. Ananworanich J, Phanuphak N, de Souza M, Paris R, Arroyo M, Trichavaroj R, Sirivichayakul S, Shikuma C, Phanuphak P, Kim JH. Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr 2008, 49:151-155. 10.1097/QAI.0b013e318183a96d, 18769355.
9. Branson BM, Stekler JD. Detection of acute HIV infection: we can't close the window. J Infect Dis 2012, 205:521-524. 10.1093/infdis/jir793, 22207652.
10. Paci P, Martini F, Bernaschi M, D'Offizi G, Castiglione F. Timely HAART initiation may pave the way for a better viral control. BMC Infect Dis 2011, 11:56. 10.1186/1471-2334-11-56, 3058048, 21362195.
11. Ananworanich J, Vandergeeten C, Schuetz A, Ridtitid W, Sereti I, Suttichom D, de Souza M, Dewar R, Chomont N, Kim JH, on behalf of the RV254/SEARCH 010 Study Group HIV reservoir size and immunity in blood and sigmoid colon of acute HIV-infected Thai subjects following 5- and 3-drug HAART [Abstract 363]. 19th Conference on Retroviruses and Opportunistic 2012, Seattle: , on behalf of the RV254/SEARCH 010 Study Group.
12. Gianella S, von Wyl V, Fischer M, Niederoest B, Battegay M, Bernasconi E, Cavassini M, Rauch A, Hirschel B, Vernazza P. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther 2011, 16:535-545. 10.3851/IMP1776, 21685541.
13. Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006, 194:725-733. 10.1086/506616, 16941337.
14. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879. 10.1097/00002030-200309050-00005, 12960819.
15. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15:893-900. 10.1038/nm.1972, 2859814, 19543283.
16. Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-arpachai M, Sriplienchan S. Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2. Virology 2007, 358:178-191. 10.1016/j.virol.2006.07.055, 16997343.
17. Bourry O, Mannioui A, Sellier P, Roucairol C, Durand-Gasselin L, Dereuddre-Bosquet N, Benech H, Roques P, Le Grand R. Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion. Retrovirology 2010, 7:78. 10.1186/1742-4690-7-78, 2955669, 20868521.
18. Luteijn R, Sciaranghella G, van Lunzen J, Nolting A, Dugast AS, Ghebremichael MS, Altfeld M, Alter G. Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control. Eur J Immunol 2011, 41:2729-2740. 10.1002/eji.201040886, 21630248.
19. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-358. 10.1038/362355a0, 8455722.
20. Robb ML, Eller LA, Eller M, Tassaneetrithep B, Sriplienchan S, Rono K, Sanga E, Sekiziyivu A, Eser A, Flach B, Shukuku K, Rono E, Sukwit S, Tovanabutra S, Nitayaphan S, Currier J, Souza M, Peel S, Kim J, Michael N, Marovich M. Viral and Lymphocyte Dynamics in Acute HIV-1 Infection: RV217-The Early Capture HIV Cohort Study (ECHO) [Abstract 27] 2011, Bangkok: , AIDS Vaccine 2011 Conference.
21. Elemans M, Thiébaut R, Kaur A, Asquith B. Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection. PLoS Comput Biol 2011, 7(3):e1001103. Epub 2011 Mar 3, 10.1371/journal.pcbi.1001103, 3048377, 21408213.
22. Ananworanich J, Vandergeeten C, Chomchey N, Phanuphak N, Ngauy V, Sekaly R, Robb M, Michael N, Kim JH, Chomont N, on behalf of the RV254/SEARCH 010 Study Group Early ART intervention restricts the seeding of the HIV reservoir in long lived central memory CD4 T cells [Abstract 47]. 20th Conferences on Retroviruses and Opportunistic Infections; Atlanta, Georgia, USA 2013, on behalf of the RV254/SEARCH 010 Study Group.
23. Goujard C, Girault I, Rouzioux C, Lecuroux C, Deveau C, Chaix ML, Jacomet C, Talamali A, Delfraissy JF, Venet A. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy. Antivir Ther 2012, 17:1001-1009. 10.3851/IMP2273, 22865544.
24. Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, Potard V, Versmisse P, Melard A, Prazuck T. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog 2013, 9:e1003211. 10.1371/journal.ppat.1003211, 3597518, 23516360.